Cutera Company Profile (NASDAQ:CUTR)

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera declared that its board has authorized a stock repurchase plan on Tuesday, August 8th 2017, which permits the company to repurchase $25,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its shares are undervalued.

Cutera, Inc. (NASDAQ:CUTR) posted its earnings results on Monday, August, 7th. The company reported $0.13 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.03 by $0.10. The business had revenue of $36.40 million for the quarter, compared to analyst estimates of $32.08 million. Cutera had a return on equity of 11.64% and a net margin of 5.07%. The firm's revenue was up 32.4% on a year-over-year basis. During the same period last year, the business posted $0.07 EPS. View Cutera's Earnings History.

4 brokerages have issued twelve-month price targets for Cutera's stock. Their predictions range from $32.00 to $39.00. On average, they expect Cutera's share price to reach $34.67 in the next year. View Analyst Ratings for Cutera.

Here are some recent quotes from research analysts about Cutera stock:

• 1. Maxim Group analysts commented, "At the Investor Day on 6/14/17, CUTR reiterated the 2Q17 and full-year 2017 guidance it originally introduced on May 1, 2017. During the Investor Day presentation, CUTR provided additional details on its five-year growth plan, highlighted by its projection of a tripling of its annual revenue to $360M in 2021, from $118M in 2016." (7/13/2017)
• 2. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (6/27/2017)

Some companies that are related to Cutera include Spirent Communications PLC (SPMYY), CEVA (CEVA), Instructure (INST), Veeco Instruments (VECO), Benefitfocus (BNFT), Cellcom Israel (CEL), Analogic Corporation (ALOG), Liberty TripAdvisor Holdings (LTRPA), PROS Holdings (PRO), Internet Initiative Japan (IIJI), ORBCOMM (ORBC), Workiva (WK), Universal Electronics (UEIC), MTS Systems Corporation (MTSC), Vocera Communications (VCRA), Cray (CRAY), Radware (RDWR) and Partner Communications Company (PTNR).

Cutera's management team includes the folowing people:

• J. Daniel Plants, Chairman of the Board
• James A. Reinstein, President, Chief Executive Officer, Director
• Darren W. Alch, Vice President, General Counsel, Secretary
• David B. Apfelberg M.D., Independent Director
• Gregory A Barrett, Independent Director
• Timothy J. O'Shea, Independent Director
• Clinton H. Severson, Independent Director
• Jerry P. Widman CPA, Independent Director

Cutera's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (8.76%), Dimensional Fund Advisors LP (5.00%), Gamco Investors INC. ET AL (4.16%), Vanguard Group Inc. (4.12%), Kennedy Capital Management Inc. (2.63%) and Lyon Street Capital LLC (2.57%). Company insiders that own Cutera stock include David A Gollnick, J Daniel Plants, Jerry P Widman, Kevin P Connors, Larry Laber, Miguel Pardos and Ronald J Santilli. View Institutional Ownership Trends for Cutera.

Cutera's stock was sold by a variety of institutional investors in the last quarter, including Lyon Street Capital LLC, Dimensional Fund Advisors LP, Menta Capital LLC, Acadian Asset Management LLC, Precept Management LLC, JPMorgan Chase & Co., Dalton Greiner Hartman Maher & Co. and Globeflex Capital L P. Company insiders that have sold Cutera stock in the last year include David A Gollnick, J Daniel Plants, Larry Laber, Miguel Pardos and Ronald J Santilli. View Insider Buying and Selling for Cutera.

Cutera's stock was purchased by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc., Stonepine Capital Management LLC, Summit Creek Advisors LLC, Ameriprise Financial Inc., EAM Investors LLC, Rice Hall James & Associates LLC, Russell Investments Group Ltd. and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Cutera.

Shares of Cutera can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Cutera stock can currently be purchased for approximately $33.75.